Which hedge funds own CHRS? COHERUS ONCOLOGY INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
4 of the hedge funds tracked by WhaleCreep disclosed a position in CHRS (COHERUS ONCOLOGY INC) in their Q2 2026 13F filings, worth $897.6k in total. The largest holder by portfolio weight is Bronte Capital at 0.0% of its book. 1 exited: Marshall Wace.
4tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold CHRS? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Bronte Capital | Q2 2026 | 0.0% | $21.4k | 15,262 | -21% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $788.3k | 563,056 | 70% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $59.0k | 42,111 | -82% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $29.0k | 20,749 | -93% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace | 0.0% | $456.4k |
How has hedge fund ownership of CHRS changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $897.6k |
| Q1 2026 | 5 | $2.0m |
| Q4 2025 | 2 | $223.2k |
| Q3 2025 | 1 | $39.5k |
| Q2 2025 | 2 | $1.0m |
| Q1 2025 | 2 | $4.7m |
| Q4 2024 | 2 | $14.5m |
| Q3 2024 | 2 | $11.3m |
| Q2 2024 | 3 | $19.2m |
| Q1 2024 | 3 | $26.5m |
| Q4 2023 | 3 | $3.1m |
| Q3 2023 | 5 | $2.5m |
| Q2 2023 | 4 | $6.4m |
| Q1 2023 | 4 | $1.1m |
| Q4 2022 | 3 | $332.3k |
| Q3 2022 | 4 | $782.0k |
Counts every tracked manager that disclosed CHRS in that quarter's filing, including managers that have since stopped filing.